Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria

2023

Letter to the Editor

Author(s)

Baumann, Katrine Y.

Bispebjerg Hospital

Jorgensen, Astrid Helene Ravn

Bispebjerg Hospital

Sørensen, Jennifer Astrup

Bispebjerg Hospital

Zhang, Ditte Georgina

Bispebjerg Hospital

Ghazanfar, Misbah Noshela

Bispebjerg Hospital

Stahl Skov, Per

RefLab ApS

Woetmann, Anders

Københavns Universitet

Vestergaard, Christian

Aarhus Universitetshospital

Maurer, Marcus

Thomsen, Simon Francis

Bispebjerg Hospital

Journal

Funder

Novo Nordisk Fonden